Literature DB >> 24106934

A dimorphic fungus causing disseminated infection in South Africa.

Chris Kenyon1, Kim Bonorchis, Craig Corcoran, Graeme Meintjes, Michael Locketz, Rannakoe Lehloenya, Hester F Vismer, Preneshni Naicker, Hans Prozesky, Marelize van Wyk, Colleen Bamford, Moira du Plooy, Gail Imrie, Sipho Dlamini, Andrew M Borman, Robert Colebunders, Cedric P Yansouni, Marc Mendelson, Nelesh P Govender.   

Abstract

BACKGROUND: The genus emmonsia contains three species that are associated with human disease. Emmonsia crescens and Emmonsia parva are the agents that cause adiaspiromycosis, and one human case of Emmonsia pasteuriana infection has been described. We report a fungal pathogen within the genus emmonsia that is most closely related to E. pasteuriana in human immunodeficiency virus (HIV)-infected adults in South Africa.
METHODS: Between July 2008 and July 2011, we conducted enhanced surveillance to identify the cause of systemic, dimorphic fungal infections in patients presenting to Groote Schuur Hospital and other hospitals affiliated with the University of Cape Town, Cape Town, South Africa. DNA sequencing was used to identify pathogenic fungi.
RESULTS: A total of 24 cases of dimorphic fungal infection were diagnosed, 13 of which were caused by an emmonsia species. All 13 patients were HIV-infected, with a median CD4+ T-cell count of 16 cells per cubic millimeter (interquartile range, 10 to 44), and all had evidence of disseminated fungal disease. Three patients died soon after presentation, but the others had a good response to a variety of antifungal agents and antiretroviral therapy. Phylogenetic analysis of five genes (LSU, ITS1-2, and the genes encoding actin, β-tubulin, and intein PRP8) revealed that this fungus belongs in the genus emmonsia and is most closely related to E. pasteuriana.
CONCLUSIONS: The findings suggest that these isolates of an emmonsia species represent a new species of dimorphic fungus that is pathogenic to humans. The species appears to be an important cause of infections in Cape Town.

Entities:  

Mesh:

Year:  2013        PMID: 24106934     DOI: 10.1056/NEJMoa1215460

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  46 in total

Review 1.  Name Changes for Fungi of Medical Importance, 2016-2017.

Authors:  David W Warnock
Journal:  J Clin Microbiol       Date:  2019-01-30       Impact factor: 5.948

2.  Antifungal Susceptibility of Emerging Dimorphic Pathogens in the Family Ajellomycetaceae.

Authors:  Karolina Dukik; Abdullah M S Al-Hatmi; Ilse Curfs-Breuker; Dirk Faro; Sybren de Hoog; Jacques F Meis
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

3.  Subterranean Mammals: Reservoirs of Infection or Overlooked Sentinels of Anthropogenic Environmental Soiling?

Authors:  Liezl Retief; Nigel C Bennett; Jennifer U M Jarvis; Armanda D S Bastos
Journal:  Ecohealth       Date:  2017-11-01       Impact factor: 3.184

4.  Single-cell analysis of innate cytokine responses to pattern recognition receptor stimulation in children across four continents.

Authors:  Philip J Cooper; Monika Esser; Arnaud Marchant; Kinga K Smolen; Bing Cai; Edgardo S Fortuno; Laura Gelinas; Martin Larsen; David P Speert; Mustapha Chamekh; Tobias R Kollmann
Journal:  J Immunol       Date:  2014-08-18       Impact factor: 5.422

5.  In Vitro Antifungal Susceptibility of Yeast and Mold Phases of Isolates of Dimorphic Fungal Pathogen Emergomyces africanus (Formerly Emmonsia sp.) from HIV-Infected South African Patients.

Authors:  Tsidiso G Maphanga; Erika Britz; Thokozile G Zulu; Ruth S Mpembe; Serisha D Naicker; Ilan S Schwartz; Nelesh P Govender
Journal:  J Clin Microbiol       Date:  2017-03-29       Impact factor: 5.948

Review 6.  Approach to Fungal Infections in Human Immunodeficiency Virus-Infected Individuals: Pneumocystis and Beyond.

Authors:  Richard J Wang; Robert F Miller; Laurence Huang
Journal:  Clin Chest Med       Date:  2017-06-03       Impact factor: 2.878

7.  Novel taxa of thermally dimorphic systemic pathogens in the Ajellomycetaceae (Onygenales).

Authors:  Karolina Dukik; Jose F Muñoz; Yanping Jiang; Peiying Feng; Lynne Sigler; J Benjamin Stielow; Joanna Freeke; Azadeh Jamalian; Bert Gerrits van den Ende; Juan G McEwen; Oliver K Clay; Ilan S Schwartz; Nelesh P Govender; Tsidiso G Maphanga; Christina A Cuomo; Leandro F Moreno; Chris Kenyon; Andrew M Borman; Sybren de Hoog
Journal:  Mycoses       Date:  2017-02-07       Impact factor: 4.377

Review 8.  Vaccine immunity against fungal infections.

Authors:  Som G Nanjappa; Bruce S Klein
Journal:  Curr Opin Immunol       Date:  2014-03-03       Impact factor: 7.486

Review 9.  Overview of vertebrate animal models of fungal infection.

Authors:  Tobias M Hohl
Journal:  J Immunol Methods       Date:  2014-04-04       Impact factor: 2.303

10.  Human Blastomycosis in South Africa Caused by Blastomyces percursus and Blastomyces emzantsi sp. nov., 1967 to 2014.

Authors:  Tsidiso G Maphanga; Monica Birkhead; José F Muñoz; Mushal Allam; Thokozile G Zulu; Christina A Cuomo; Ilan S Schwartz; Arshad Ismail; Serisha D Naicker; Ruth S Mpembe; Craig Corcoran; Sybren de Hoog; Chris Kenyon; Andrew M Borman; John A Frean; Nelesh P Govender
Journal:  J Clin Microbiol       Date:  2020-02-24       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.